遺伝子検査のジェネシスヘルスケア株式会社

Genesis Healthcare announces share issue of 1.4Bil yen to Rakuten

AUGUST 21, 2017
Genesis Healthcare Co.

Genesis Healthcare (Dr. Iri Sato Baran, Co-founder and President) has announced that it has completed a 1.4 Billion Yen issue of new shares to Rakuten. Furthermore, Rakuten’s Chairman and CEO will join Genesis Healthcare’s Board of Directors as an External Board Director. As a result of the new investment, Genesis Healthcare’s capital will increase to 2.1 Billion Yen, one of the largest paid-in-capital levels among genetic testing companies in Japan.

Genesis Healthcare, founded in 2004, already manages one of the largest genetic databases in Asia and Japan, with approximately 520,000 individuals as of August, 2017, and plans to increase its database size to one million by 2020. While Genesis Healthcare offers various genetic testing services to the government, medical, academia, industry and consumers, it also offers healthcare and disease prevention test kits and IT services under the consumer brand “GeneLife” in order to enrich people’s lives through personalized genetic testing.

Genesis Healthcare’s Co-Founder and President, Dr. Iri Sato Baran commented :“The investment by Rakuten, a Japan leader in Internet services, will allow us to increase awareness of genetic information technology through digital healthcare for the betterment of personalized health and self-medication.”

“Forward-thinking technologies like Genesis Healthcare’s genetic health analysis and a deeper understanding of responsible self-medication are essential to finding innovative responses to increasing health costs and the rising awareness of health issues in Japan,” commented the Rakuten Chairman and CEO, Hiroshi “Mickey” Mikitani. “With this investment, we would like to see Genesis Healthcare take a leading role in furthering the understanding and adoption of genetic health testing in Japan.”

Genesis Healthcare plans to use the new funding mainly to promote genetic testing and investment into IT and R&D.
It will also continue to accelerate its marketing programs, as well as strengthen recruiting and training efforts. Genesis Healthcare will continue to contribute to the improvement of quality of life through genetic diagnostic technologies.

Genesis Healthcare Co.
Corporate site: www.genesis-healthcare.jp
Press Inquiries:Public Relations Division
TEL:+81-3-5422-8506 
Attention; Public Relations Div
E-mail: infogene@genelife.jp

Copyright © GENESIS HEALTHCARE CO. All Rights Reserved.

up